Feed Top Reports Pricing

⌘K

16:00:23·41d

SECFiling

SEC Form DEF 14A filed by Abbott Laboratories

ABT· Abbott Laboratories

Health Care

Full content unavailable. See the original source below.

Original source

Companies

ABT
Abbott Laboratories
Health Care

Recent analyst ratings

Apr 22UpdateDaiwa Securities$92.00
Oct 10UpdateThe Benchmark Company$145.00
Jul 18UpdateJefferies$145.00
Jun 16UpdateLeerink Partners$143.00
Oct 8UpdateOppenheimer$130.00
Sep 19UpdatePiper Sandler$131.00

Related

ANALYST1d
Abbott Labs downgraded by Daiwa Securities with a new price target
SEC6d
Abbott Laboratories filed SEC Form 8-K: Other Events, Financial Statements and Exhibits
PR6d
New data at AACR 2026 demonstrate advancements in Cancerguard® Multi-Cancer Early Detection Test
SEC7d
Abbott Laboratories filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
PR7d
Abbott Reports First-Quarter 2026 Results; Updates Guidance to Reflect Acquisition of Exact Sciences
PR14d
New survey finds most Americans believe chronic diseases are preventable, but only 1 in 4 feel confident in how to care for their health
INSIDER21d
SEC Form 4 filed by Stratton John G
INSIDER21d
SEC Form 4 filed by Roman Michael F

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releases Analyst ratings Insider trading FDA SEC RSS feeds

Top lists

Trending By market cap Active companies Analyst upgrades Insider purchases FDA approvals SEC filings Sectors Market reports

Company

About Pricing Publish with us Contact

Legal

Terms of use Privacy policy Cookie policy

© 2026 quantisnow.com · Democratizing insights since 2022